Literature DB >> 33502697

Added value gated PET with phase analysis for the detection of scar burden and prognostication in cardiac sarcoidosis?

Thomas H Schindler1,2, Adeel Haq3, Sudhir Jain4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33502697     DOI： 10.1007/s12350-021-02530-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   3.872


× No keyword cloud information.
  5 in total

1.  18F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis.

Authors:  Sho Furuya; Masanao Naya; Osamu Manabe; Kenji Hirata; Hiroshi Ohira; Tadao Aikawa; Kazuhiro Koyanagawa; Keiichi Magota; Ichizo Tsujino; Toshihisa Anzai; Yuji Kuge; Noriko Oyama-Manabe; Kohsuke Kudo; Tohru Shiga; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2019-12-09       Impact factor: 5.952

Review 2.  Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Authors:  Ernest V Garcia; Piotr Slomka; Jonathan B Moody; Guido Germano; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-10-25       Impact factor: 5.952

3.  Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?

Authors:  Georgios Benetos; Andreas A Giannopoulos
Journal:  J Nucl Cardiol       Date:  2019-12-02       Impact factor: 5.952

Review 4.  Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.

Authors:  Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2020-10-16       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.